Helixmith Co., Ltd
KOE: 084990.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sunyoung Kim D.Phil.,
- Employees
- 132
- Headquarters
- Seoul, South Korea
- IPO year
- 2005
- Market cap
- ₩364.7B
- Website
- https://www.helixmith.com
Loading 084990…
Loading profile data…Frequently asked questions about 084990
What does Helixmith Co., Ltd (084990.KQ) do?
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202,...
Where does 084990.KQ trade?
Helixmith Co., Ltd (084990.KQ) trades on the KOSDAQ.
What sector is 084990.KQ in?
Helixmith Co., Ltd (084990.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Helixmith Co., Ltd?
Sunyoung Kim D.Phil., is the chief executive officer of Helixmith Co., Ltd (084990.KQ).
Where is Helixmith Co., Ltd headquartered?
Helixmith Co., Ltd is headquartered in South Korea.
Does 084990.KQ pay a dividend?
Helixmith Co., Ltd (084990.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 084990.KQ go public?
Helixmith Co., Ltd (084990.KQ) completed its initial public offering in 2005.